Cronos Group Inc (CRON)

[guay]

Cronos Group ($CRON) has attracted investors over the last few weeks. This week the company announced financial results for the second quarter ended June 30, 2018. Key highlights of these earnings included second quarter 2018 revenues totaling $3.4 million, as compared to $0.6 million for the second quarter 2017, representing an increase of $2.8 million, or 428%.

According to the company, the main drivers associated with the increase in revenues are an expansion in patient onboarding, an increase in average sales price and the continued strong growth in our cannabis oil offering. Second quarter 2018 cannabis oil sales accounted for 40% of domestic medical sales. Furthermore, finished goods inventory and biological assets increased by 46% quarter-over-quarter to 2,451 kilograms as the Company said it will focus on building inventory for the adult-use market.

https://finance.yahoo.com/news/marijuana-stocks-market-outlook-2018-150000555.html